首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1529384

全球筋膜室症候群治療市場 - 2024-2031

Global Compartment Syndrome Treatment Market - 2024-2031

出版日期: 2024年08月06日 | 出版商:

DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球筋膜室症候群治療市場規模達3.168億美元，預計2031年將達到5.166億美元，2024-2031年預測期間複合年成長率為6.3%。

筋膜室症候群是一種痛苦的情況，當肌肉內的壓力達到危險水平時就會發生。這種壓力會減少血流量，阻止營養和氧氣到達神經和肌肉細胞。筋膜室症候群可以是急性的（短期內出現嚴重症狀），也可以是慢性的（長期持續）。

急性骨筋膜室症候群是一種外科急症。沒有有效的非手術治療方法。切口並切開覆蓋受影響隔間的皮膚和筋膜。此手術稱為筋膜切開術。

慢性骨筋膜室症候群是一種非手術治療方法。物理治療、矯正器（鞋墊）和抗發炎藥物對於緩解症狀的效果可能有限，通常無法恢復全面活動。

用於行為綜合症治療的藥物包括鴉片類藥物、非鴉片類藥物和非類固醇抗發炎藥。該市場是由創傷發生率增加和治療技術進步等因素推動的。

市場動態：

司機

外傷發生率增加

全球筋膜室症候群治療市場的需求是由多種因素所驅動的。外傷發生率的增加預計將推動市場的成長。交通事故、運動傷害和戰鬥傷害等外傷是導致骨筋膜室症候群的主要原因。

急性骨筋膜室症候群 (ACS) 最常在重大創傷後不久發生，尤其是長骨骨折。根據 2023 年 1 月的 Medscape 新聞報導，腹部筋膜室症候群在創傷 ICU 入院的頻率為 5% 至 15%，在普通創傷入院的頻率為 1%。

此外，該行業的主要參與者正在進行的研究將推動該市場的成長。根據 NCBI 2024 年 3 月的研究出版物，2015 年至 2022 年期間，共有 13,305 例創傷性骨筋膜室症候群病例。其中，61%出現在下肢，11%出現在上肢。很大一部分病例缺乏精確的定位分類（25.2%）。大多數創傷性骨筋膜室症候群發生在男性（女性 4092 例，男性 9213 例）。

同樣，根據 EFFORT 2023 年 12 月的公開評論，脛骨骨折中的 ACS 根據損傷部位的不同而有所不同，脛骨平台骨折的 ACS 約為 12%，在高能量模式中高達 53%。

限制

治療費用高昂、治療選擇有限以及個人意識和診斷有限等因素預計將阻礙市場。

有關此報告的更多詳細資訊 - 索取樣本

Compartment syndrome is a painful condition that occurs when pressure within the muscles builds to dangerous levels. This pressure can decrease blood flow, which prevents nourishment and oxygen from reaching nerve and muscle cells. Compartment syndrome can be either acute (having severe symptoms for a short period) or chronic (long-lasting).

Acute compartment syndrome is a surgical emergency. There is no effective nonsurgical treatment. An incision and cut open the skin and fascia covering the affected compartment. This procedure is called a fasciotomy.

Chronic compartment syndrome is a nonsurgical treatment. Physical therapy, orthotics (inserts for shoes), and anti-inflammatory medicines may be of limited benefit in relieving symptoms and generally do not allow a return to full activity.

Drugs used for comportment syndrome treatment involve opioids, non-opioids, and NSAIDs. The market is driven by factors such as the increasing incidence of traumatic injuries and technological advancements in treatment.

Market Dynamics: Drivers

Increasing incidence of traumatic injuries

The demand for the global compartment syndrome treatment market is driven by multiple factors. The increasing incidence of traumatic injuries is expected to drive the growth of the market. Traumatic injuries, such as road accidents, sports injuries, and combat injuries, are major causes of compartment syndrome.

Acute compartment syndrome (ACS) most often develops soon after significant trauma, particularly involving long bone fractures. According to Medscape news in January 2023, the frequency of abdominal compartment syndrome in trauma ICU admissions is anywhere from 5 to 15% and 1% of general trauma admissions.

Moreover, major players in the industry's ongoing research studies would propel this market growth. According to an NCBI research publication in March 2024, during the period from 2015 to 2022, a total of 13,305 cases of traumatic compartment syndromes. Of these, 61% manifested in the lower extremities and 11% in the upper extremities. A significant portion of cases lacked precise localization classification (25.2%). Most traumatic compartment syndromes occurred in males (4092 cases in females vs. 9213 in males).

Similarly, as per EFFORT open reviews in December 2023, ACS in tibial fractures varies depending on the injury site, around 12% for tibial plateau fractures, reaching up to 53% in higher-energy patterns.

Restraints

Factors such as the high cost of treatment, the availability of limited treatment options, and limited awareness & diagnosis among individuals, are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global compartment syndrome treatment market is segmented based on treatment type, syndrome type, end-users, and region.

The fasciotomy segment accounted for approximately 51.3% of the global compartment syndrome treatment market share

The fasciotomy segment is expected to hold the largest market share over the forecast period. Fascia are the thick sheets of connective tissue that surround muscle compartments. Fasciotomy, a procedure in which the fascia is cut to relieve pressure in the muscle compartment, is used to treat people with acute or chronic compartment syndrome.

A fasciotomy consists of 1 or more fascial incisions and remains the only effective way to treat acute compartment syndrome. Fasciotomy is a surgical procedure that involves making an incision in the skin and underlying tissue to relieve pressure on the affected nerve or muscle. According to Healio news in April 2024, Atraumatic idiopathic compartment syndrome requiring emergent fasciotomy.

Moreover, key players in the market technological advancements in fasciotomy drive the market growth. The development of advanced intracompartmental pressure monitoring devices enhances the accuracy and reliability of diagnosing compartment syndrome, guiding surgeons in determining the necessity and timing of fasciotomy.

As per NCBI publication in March 2024, an FDA-approved device was used for continuous compartment pressure monitoring. The sensor tip is placed in the muscle belly, and the trochar is then detached from the sensor, allowing the sensor to remain in place. Innovations in imaging technologies, such as portable ultrasound devices, aid in pre-operative planning and intraoperative assessment during fasciotomy procedures.

Geographical Analysis

North America accounted for approximately 43.8% of the global compartment syndrome treatment market share.

North America region is expected to hold the largest market share over the forecast period owing to the high incidence of trauma and sports-related injuries as per NCBI April 2024, the incidence of ACS is estimated to be 7.3 per 100,000 in males and 0.7 per 100,000 in females.

According to the National Safety Council in 2023, 3.7 million people were treated in emergency departments for injuries involving sports and recreational equipment. The activities most frequently associated with injuries are exercise, cycling, and basketball. Amongst American children and adolescents, sports and recreational activities contribute to the growth of the market.

Moreover, key player's innovative initiatives, growing awareness of the syndrome, advancements in medical technology, and increased focus on sports medicine propel this market growth in this region. For instance, in August 2023, Sentinel Medical Technologies addressed the IAP transducer shortage with the trauma ward. IAP monitoring is a critical component of patient care in OR and ICU settings. It serves as a crucial guide for medical teams in assessing the risk of developing Intra-Abdominal Hypertension (IAH) and Abdominal Compartment Syndrome (ACS), conditions that can have severe consequences if not addressed promptly.

Market Segmentation

By Treatment Type

Fasciotomy
Orthotics
Drugs
- Opioids
- Non-Opioids
- NSAIDs

By Syndrome Type

Acute Compartment Syndrome
Chronic Compartment Syndrome

By End-User

Hospitals & Clinics
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- The rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the compartment syndrome treatment market include Stryker, BD, C2DX, Inc., Accuryn Medical, Medline Industries, LP., MY01, Convatec Inc., RAUMEDIC AG, Millar, LLC, and Mirador Biomedical among others.

Key Developments

In May 2021, MY01 Inc. received FDA clearance for the MY01 continuous compartment pressure monitor as an aid in the diagnosis of compartment syndrome.

Why Purchase the Report?

To visualize the global compartment syndrome treatment market segmentation based on treatment type, syndrome type, end-users, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the compartment syndrome treatment market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.

The global compartment syndrome treatment market report would provide approximately 62 tables, 58 figures, and 181 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Treatment Type
3.2. Snippet by Syndrome Type
3.3. Snippet by End-Users
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Incidence of Traumatic Injuries
  - 4.1.1.2. Technological Advancements in Treatment
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Treatment
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Treatment Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 6.1.2. Market Attractiveness Index, By Treatment Type
6.2. Fasciotomy *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Orthotics
6.4. Drugs
- 6.4.1. Opioids
- 6.4.2. Non-Opioids
- 6.4.3. NSAIDs

7. By Syndrome Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type Market Attractiveness Index, By Syndrome Type
7.2. Acute Compartment Syndrome*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chronic Compartment Syndrome

8. By End-Users

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
- 8.1.2. Market Attractiveness Index, By End-Users
8.2. Hospitals & Clinics *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers
8.4. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Stryker *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. BD
11.3. C2DX, Inc
11.4. Accuryn Medical
11.5. Medline Industries, LP.
11.6. MY01
11.7. Convatec Inc
11.8. RAUMEDIC AG
11.9. Millar, LLC
11.10. Mirador Biomedical

LIST NOT EXHAUSTIVE